Elisigen
PrivateLast Round
Series C
Jan 19, 2026
Est. Valuation
$179M
Total Funding Raised
$78.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elisigen is a biotechnology company that develops AAV-based gene therapies to treat retinal and neurological diseases.
Sector
Enterprise Software
Verticals
Workflow Automation, Project Management, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elisigen Comparables
Compare Elisigen with similar companies based on industry and business-model similarity.
No public comparables are available for Elisigen. Request access to learn about comparables coverage.
Request accessElisigen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 19, 2026 | ||||
| Series B | Jun 3, 2021 | ||||
| Series A | Apr 30, 2019 | ||||
| Seed | Oct 25, 2018 |
Elisigen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B |
| KB Investment | Series C |
| Seven Tree Equity Partners | Series B |
| Ulmus Investment | Series B |
| Premier Partners | Series C |
| NICE F&I | Series C |
| QUAD Investment Management | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
$29M round with participation from NH Investment & Securities and Premier Partners.
- May 21, 2024
Grew 67% QoQ, from 6 to 10 employees.
Elisigen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elisigen's valuation, stock price, and market status.
Is Elisigen a public or private company?
Elisigen is a private company.
What is the current stock price of Elisigen?
Elisigen is a private company with no public stock price. Caplight tracks Elisigen's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Elisigen worth (valuation)?
Elisigen's valuation is estimated at $179.0M based on funding round data.
Can I buy Elisigen stock?
Elisigen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elisigen's last funding round?
Elisigen's most recent funding round was Series C on June 3, 2021.
Who are the main investors in Elisigen?
Key investors in Elisigen include SV Investment, KB Investment, Seven Tree Equity Partners, Ulmus Investment, Premier Partners.
Will Elisigen IPO soon?
No public IPO plans have been announced for Elisigen.
How can I track Elisigen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elisigen's secondary market activity and sign up for updates.